Study finds how bacterial vaccine demonstrates potential as treatment for cancer immunotherapy
Columbia researchers developed probiotic bacteria that train the immune system to eliminate cancer cells, paving the way for a new class of cancer vaccinations that take advantage of bacteria’s innate tumour-targeting abilities. Read further on Dynamite News: